A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

NCT01668537 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

651

Enrollment

INDUSTRY

Sponsor class

Conditions

Smallpox

Interventions

BIOLOGICAL: LF formulation of IMVAMUNE®
BIOLOGICAL: FD formulation of IMVAMUNE®

Sponsor

Bavarian Nordic